Emerging evidence highlights psilocybin as a potential therapy for treatment-resistant OCD, while cannabinoids show limited ...

By increasing neuroplasticity, psychedelics may both enhance creativity and be useful for treating a variety of psychiatric ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

Psilocybin, a classic psychedelic, has therapeutic potential for psychiatric disorders. A specific brain circuit and receptor have now been found to be required for psilocybin’s long-term effects on ...

Sept. 11, 2025 -- Psychedelics like ketamine, psilocybin, and MDMA are emerging as promising treatments for mood disorders that don’t respond to standard care. What has research shown using these ...

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric ...

If we travelled back 16,500 years to visit North America during the Ice Age, research suggests we would see our ancestors making use of psychedelic mushrooms. From cacti in ancient Mexico to ergot ...

When David Luke committed to studying psychedelics and parapsychology, it felt like double career suicide. Today, elite institutions have his back as he explores DMT “entities,” near-death experiences ...

BUFFALO, N.Y. – The increasing availability of legal psychedelic therapy programs, such as those in Colorado and Oregon, has led researchers to take a broader look into various aspects of how people ...